Category: Regulatory/FDA

CHC_general1

09/25/2019

FDA Amps Up Foreign Inspections Under Pressure to Bend on Opposition to Drug Importation

CHC_DTCadvertisement2

09/16/2019

OPDP DTC Research Studies Await Peer Review, Are Poised for Publication

CHC_FDA-Regulatory Images1

09/09/2019

OPDP Warning Letter: Omission of Risk Info in DTC Print Ad/Display Banners Misbrands ED Drug

doctor story

08/26/2019

OPDP to Study How Source, Graphics and Time Affect Physician Perceptions of Info

CHC_FDA-Regulatory Images1

08/05/2019

Latest OPDP Enforcement Letters: Don’t Omit or Distract from Risk Information

News Aikin

07/22/2019

OPDP’s Aikin Highlights Role of Social Science Research in FDA Promotional Policymaking

Myers News

07/01/2019

FDA’s Second Half: Org Changes, Updating Trial Design and Promotional Regulation, 2020 Budget

CHC_FDA-Regulatory Images1

06/19/2019

OPDP Untitled Letter Cites False, Misleading Claims about Efficacy, Risk Presentation for Obesity Drug

Myers News

06/03/2019

FDA After Gottlieb: Will Sharpless Stay the Course?